Delayed myelination in a mouse model of fragile X syndrome

Area of Science:

• Neuroscience
• Developmental Biology
• Genetics

Background:

• Fragile X Syndrome (FXS) is the leading inherited cause of autism spectrum disorder.
• Fragile X mental retardation protein (FMRP) regulates mRNA translation and is crucial for neuronal function.
• The role of FMRP in developing glial cells, particularly in myelination, is not well understood.

Purpose of the Study:

• To investigate the role of FMRP in early brain development, specifically focusing on myelination in the cerebellum.
• To determine if FMRP deficiency affects oligodendrocyte precursor cells and myelination in a mouse model of FXS.

Main Methods:

• Utilized Fmr1 knockout (FXS) mice and wild-type littermates.
• Employed diffusion tensor magnetic resonance imaging (DT-MRI) and electron microscopy to assess cerebellar myelination.
• Quantified myelin basic protein expression, myelinated axon counts, and myelin sheath thickness.
• Analyzed oligodendrocyte precursor cell populations (PDGFRα+/NG2+).

Main Results:

• Fmr1 knockout mice exhibited reduced cerebellar volume and significant deficits in myelination by postnatal day 7 (PND 7).
• A marked reduction (80-85%) in myelin basic protein expression, fewer myelinated axons, and thinner myelin sheaths were observed in FXS mice.
• Oligodendrocyte precursor cell numbers and NG2 expression were decreased in the Fmr1 cerebellum at PND 7.
• Myelination deficits showed partial recovery by PND 30, suggesting a delay rather than complete absence.

Conclusions:

• Impaired maturation or function of oligodendrocyte precursor cells contributes to delayed myelination in the Fmr1 mouse model.
• White matter abnormalities in early postnatal development are a significant neurological deficit in Fragile X Syndrome.
• These findings highlight the importance of glial cell function in the neurological underpinnings of FXS.